News
-
07.11.2022Perkins Coie Lawyers Mentioned in Law360—Google Attacks Sonos' Speaker Tech At Fed. Circ.General NewsDan Bagatell, Nathan Kelley, Jonathan Tietz, Andrew Dufresne, Theresa Nguyen and Tara Kurtis were mentioned in the Law360 article “Google Attacks Sonos' Speaker Tech At Fed. Circ." regarding their representation of Google in a patent infringement case.
-
07.06.2022Perkins Coie Wins Federal Circuit Appeal for Client U.D. Electronic Corp.General NewsPerkins Coie is pleased to announce that it has achieved a victory in the U.S. Court of Appeals for the Federal Circuit on behalf of client U.D. Electronic Corp., a global Ethernet solutions provider, after Pulse Electronics, Inc., alleged that electrical connectors commonly used for Ethernet networking manufactured by U.D. Electronic infringed four of its U.S. patents.
-
06.02.2022Perkins Coie Wins Federal Circuit Appeal for Client U.D. Electronic Corp.Press ReleasesPerkins Coie is pleased to announce that it has achieved a victory in the U.S. Court of Appeals for the Federal Circuit on behalf of client U.D. Electronic Corp., a global Ethernet solutions provider, after Pulse Electronics, Inc., alleged that electrical connectors commonly used for Ethernet networking manufactured by U.D. Electronic infringed four of its U.S. patents.
-
03.01.20222022 Pro Bono ReportGeneral NewsThrough our pro bono efforts, our firm responded to needs worldwide by helping Afghans desperate to escape the turmoil in their country, bolstering our new virtual program to help survivors of domestic violence, and expanding disability rights for veterans. The stories in this report highlight our efforts, in partnership with legal service providers across the country, to make a positive impact through pro bono service.
-
11.02.2021Perkins Coie Attorneys Mentioned in Law360—Fintiv Fails: PTAB Uses 'Remarkably Inaccurate' Trial DatesGeneral News
Law360
Andrew Dufresne and Nathan Kelley were mentioned in “Fintiv Fails: PTAB Uses 'Remarkably Inaccurate' Trial Dates,” an article in Law360, regarding our attorneys findings that the vast majority of cases where Patent Trial and Appeal Board petitions were turned away based on related trial dates had the trials extended by several months.
-
08.26.2021Best Lawyers® 2022 Recognizes 367 Perkins Coie AttorneysPress ReleasesPerkins Coie is proud to announce that 367 of its attorneys were recognized by the 2022 Best Lawyers®. A total of 278 attorneys were selected by their peers for inclusion in the 2022 edition of The Best Lawyers in America® and 89 attorneys were selected for inclusion in the 2022 edition of Best Lawyers: Ones to Watch.
-
10.20.2020Perkins Coie Attorneys Mentioned in Law360—USPTO, Tech Titans Urge Judge Not to Halt All IPRsGeneral News
Law360
Daniel Shvodian, Reese Nguyen, and Andrew Dufresne were mentioned in the Law360 article, "USPTO, Tech Titans Urge Judge Not to Halt All IPRs," regarding their representation of Google in Apple Inc. et al. v. Iancu, case number 5:20-cv-06128, in the U.S. District Court for the Northern District of California. -
08.20.2020Best Lawyers® 2021 Recognizes 358 Perkins Coie AttorneysPress ReleasesPerkins Coie is proud to announce that 358 of its attorneys were recognized by Best Lawyers® 2021. A total of 290 attorneys were selected by their peers for inclusion in the 2021 edition of The Best Lawyers in America® and 68 attorneys were selected for inclusion in the inaugural edition of Best Lawyers: Ones to Watch.
-
01.02.2020Perkins Coie Announces 2020 Partner ClassPress ReleasesPerkins Coie is pleased to announce that 29 counsel and senior counsel have been promoted to partner.
-
05.15.2019Perkins Coie Attorneys Mentioned in Law360 - Fed. Circ. Kills 2 Patents on Horizon Pain Drug VimovoGeneral News
Law360
Andrew Dufresne, Autumn Nero, Dan Bagatell and Shannon Bloodworth were mentioned in the Law360 article, "Fed. Circ. Kills 2 Patents on Horizon Pain Drug Vimovo," as representation for Mylan when the U.S. Court of Appeals for the Federal Circuit ruled that two patents on Horizon Pharma's Vimovo are invalid. -
04.17.2019Perkins Coie Attorneys in the Madison Office Recognized by the State Bar of Wisconsin Regarding Their Pro Bono ContributionsGeneral News
The attorneys in the Madison office of Perkins Coie LLP are recognized for their outstanding pro bono contributions. The 24 attorneys in the firm’s Madison office contributed 1,962 hours of pro bono time in 2018.
-
09.28.2018Andrew Dufrense Quoted in Law360 - Fed. Circ. Flips 1954 Disability Denial To Korean War VetGeneral News
Andrew Dufrense quoted in "Fed. Circ. Flips 1954 Disability Denial To Korean War Vet" a Law360* article regarding the overruling of a denial of benefits for an army veteran 60 years ago.
*subscription based publication
-
07.27.2018Perkins Coie Lawyers Mentioned in Law360 - Riddell Scores On Most Claims In Helmet Patent RowGeneral NewsPerkins Coie lawyers mentioned in “Riddell Scores On Most Claims In Helmet Patent Row,” a Law360 article regarding Riddell’s win on several claims against competitor for patent infringement.
-
05.15.2018Perkins Coie Announces Life Sciences Blog: 1600 PTAB & BeyondPress ReleasesPerkins Coie is proud to announce the launch of 1600 PTAB & Beyond, a blog that reports from the intersection of the life sciences industry and key decisions and developments from the Patent Trial and Appeal Board (PTAB), district courts and appellate courts.
-
04.20.2018Perkins Coie Attorneys Noted as Counsel in the Law.com Article - Skilled in the Art: The Brave New World of Section 101 GuidanceGeneral News
Law.com
Perkins Coie was noted as counsel to Mylan, Teva and Akorn in the Law.com article, "Skilled in the Art: The Brave New World of Section 101 Guidance," which discusses whether Native American tribal immunity protects patents from inter partes review. -
04.19.2018Perkins Coie Team Noted as Counsel to Mylan in the Law360 Article - Allergan, Tribe Fight PTAB's Immunity Denial at Fed. Circ.General News
Law360
Perkins Coie attorney Brandon White was noted as counsel to Mylan in the Law360 article, “Allergan, Tribe Fight PTAB's Immunity Denial at Fed. Circ.,” regarding The Patent Trial and Appeal Board going against decades of U.S. Supreme Court precedent. -
03.26.2018Perkins Coie Team Noted as Counsel to Mylan in the Law360 Article - Generic Cos. Tell Fed. Circ. Not To Halt PTAB Restasis IPRsGeneral News
Law360
Perkins Coie attorneys Eric Miller, Charles Curtis, Andrew Dufresne, Shannon Bloodworth, Brandon White and Dan Bagatell were noted as counsel to Mylan in the Law360 article, "Generic Cos. Tell Fed. Circ. Not To Halt PTAB Restasis IPRs," regarding the Patent Trial and Appeal Board's review of patents. -
03.19.2018Perkins Coie Team Mentioned in Law360 - Tribe Asks Fed. Circ. To Pause Restasis Patent ReviewsGeneral News
Law360
The Perkins Coie team representing Mylan was mentioned in the Law360 article, “Tribe Asks Fed. Circ. To Pause Restasis Patent Reviews,” regarding the Federal Circuit being asked to stop the Patent Trial and Appeal Board’s review of certain patents.